Senseonics Holdings Inc (SENS)
0.3316
-0.01
(-1.63%)
USD |
NYAM |
Nov 05, 16:00
0.3355
0.00 (0.00%)
After-Hours: 18:24
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 177.60M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -37.12% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 8.406 |
Price to Book Value | 307.26 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 91.43 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 93.88% |
Profile
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States. |
URL | https://www.senseonics.com |
Investor Relations URL | N/A |
HQ State/Province | Maryland |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Small Cap/Blend |
Next Earnings Release | Nov. 07, 2024 |
Last Earnings Release | Aug. 08, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States. |
URL | https://www.senseonics.com |
Investor Relations URL | N/A |
HQ State/Province | Maryland |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Small Cap/Blend |
Next Earnings Release | Nov. 07, 2024 |
Last Earnings Release | Aug. 08, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |